跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPSYNVI 10/40 macitentan 10 mg / tadalafil 40 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
OPSYNVI 10/40 macitentan 10 mg / tadalafil 40 mg film-coated tablet blister pack
Approved
STANDARD
OPSYNVI 10/40 macitentan 10 mg / tadalafil 40 mg film-coated tablet blister pack
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
fef3724ad32a15f0
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
fef3724ad32a15f0
Product Name
OPSYNVI 10/40 macitentan 10 mg / tadalafil 40 mg film-coated tablet blister pack
Artg Id
420130
Artg Name
OPSYNVI 10/40 macitentan 10 mg / tadalafil 40 mg film-coated tablet blister pack
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2024-09-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e7117bb29a5ef9c6453f9c32c78f7dec.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/95dc336ee1558182c4f1fe51a79f35b6.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
fef3724ad32a15f0
Type
Standard
Back to TGA Approvals